WARREN C FISKUS to Febrile Neutropenia
This is a "connection" page, showing publications WARREN C FISKUS has written about Febrile Neutropenia.
Connection Strength
0.040
-
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Am J Hematol. 2019 01; 94(1):74-79.
Score: 0.040